6.09 USD
▲+0.12+4.46%
盘后 5.91 +1.37%
2026-08-03
市值
$1.86B
市盈率
—
EPS
-0.48
股息率
—
52 周区间
2.75 – 8.44
成交量
3.97M
Beta
1.15
目标价
10.50
52W 低 2.7552W 高 8.44
价格走势
公司简介
AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lil...